Innovation.gsk.com is a subdomain of gsk.com, which was created on 1998-08-07,making it 26 years ago. It has several subdomains, such as my.gsk.com cz.gsk.com , among others.
Description:We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease...
Discover innovation.gsk.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 188.072 KB |
Page Load Time: 0.265196 Seconds |
Website IP Address: 34.160.236.144 |
Home | GSK AU au.gsk.com |
Disease Education | Immunology | GSK US Medical Affairs sleeducatorsnetwork.gskusmedicalaffairs.com |
Agreement to acquire TESARO | GSK ir.tesarobio.com |
Colgate sues GSK over toothpaste 'nurdle' image | DrBicuspid.com 305278.drbicuspid.com |
Cache-Control: no-cache |
Pragma: no-cache |
Content-Type: text/html; charset=utf-8 |
Expires: -1,0 |
X-XSS-Protection: 1; mode=block |
X-Content-Type-Options: nosniff |
Access-Control-Allow-Origin: https://jobs.gsk.com |
Access-Control-Allow-Credentials: true |
Access-Control-Allow-Headers: Authorization |
X-Frame-Options: SAMEORIGIN |
Content-Security-Policy: "default-src self unsafe-eval unsafe-inline * data:; frame-ancestors self; frame-src self *", Date: Tue, 14 May 2024 04:58:36 GMT |
Content-Length: 274370 |
Via: 1.1 google |
Alt-Svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000 |
charset="utf-8"/ |
content="IE=edge" http-equiv="X-UA-Compatible"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="Company | GSK " property="og:title" |
content="website" property="og:type" |
content="https://www.gsk.com/en-gb/company/" property="og:url" |
content="We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together" name="description"/ |
content="We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together" property="og:description"/ |
content="https://www.gsk.com/media/8483/web02-header-immuno_oncology_octane_ry_6k_still-copy.jpg?anchor=center&mode=crop&quality=90&width=600&height=315&rnd=133003832500000000" name="image" property="og:image"/ |
content="400" property="og:image:width"/ |
content="300" property="og:image:height"/ |
content="summary_large_image" name="twitter:card"/ |
content="@gsk" name="twitter:site"/ |
content="Company | GSK" name="twitter:title"/ |
content="We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together" name="twitter:description"/ |
content="https://www.gsk.com/media/8483/web02-header-immuno_oncology_octane_ry_6k_still-copy.jpg?anchor=center&mode=crop&quality=90&width=600&height=315&rnd=133003832500000000" name="twitter:image"/ |
content="https://www.gsk.com/media/8483/web02-header-immuno_oncology_octane_ry_6k_still-copy.jpg?anchor=center&mode=crop&quality=90&width=600&height=315&rnd=133003832500000000" name="page-image" |
content="Company" name="site-section" |
Ip Country: United States |
City Name: Kansas City |
Latitude: 39.1027 |
Longitude: -94.5778 |
Company Back to main Company Company Purpose, strategy and culture Outstanding people Company Outstanding people Working together My GSK story Innovating together 2022 Innovating together 2021 GSK at a glance History and heritage Board of directors and leadership team Board information Governance Company Governance Committees Shareholders Sarbanes-Oxley Act 2002 Compliance Policy positions Codes, standards and reports FEATURED SECTION Our purpose, strategy and culture FEATURED SECTION Outstanding peopleInnovation Back to main Innovation Innovation Research and development approach Pipeline Therapeutic areas Innovation Therapeutic areas Infectious diseases HIV Respiratory/immunology Oncology Technologies Clinical trials at GSK Innovation Clinical trials at GSK Provision of unlicensed medicines for unmet medical needs Data transparency Diversity in clinical trials Partnering with GSK Innovation Partnering with GSK Supported studies R&D locations SPOTLIGHT ON Behind the science magazine Featured section Partnering with GSKProducts Back to main Products Products Our product areas Products A-Z SPOTLIGHT ON Innovation FEATURED WEBSITE GSKPro for healthcare professionalsResponsibility Back to main Responsibility Responsibility Access Global health and health security Responsibility Global health and health security Global health Health security Using our science for global health Improving access to healthcare Environment Responsibility Environment Climate Freshwater Land Oceans Atmosphere Materials and waste Diversity, equity and inclusion Ethical standards Responsibility Ethical standards Working with third parties Public policy and patient advocacy Human rights Use of animals Engaging with healthcare professionals Product governance Charitable Investments ESG resources Responsibility ESG resources ESG reports archive FEATURED SECTION Diversity equity and inclusion SPOTLIGHT ON Our policy positionsInvestors Back to main Investors Investors Why invest in GSK? Quarterly results Financial reports Investors Financial reports Annual Report 2023 Corporate reports archive Environmental, social and governance Speeches and presentations Science publications Events calendar Dividend and share price Investors Dividend and share price GSK share price Share price calculators (GBp/USD) Dividend calculators (GBp/USD) Dividend calendar Analyst consensus Stock exchange announcements Investors Stock exchange announcements London (RNS) London (RNS) inside information New York (SEC) Sign up for announcements Shareholder information Investors Shareholder information Manage your shares Annual General Meeting General Meeting Annual Governance Meeting Corporate sponsored nominee service Our ADR programme Asset reunification - ProSearch Share scam alert Privacy notice for ordinary shareholders FAQs Corporate actions Investors Corporate actions Consumer Healthcare Demerger Consumer Healthcare Joint Venture Agreement to acquire TESARO Debt investors Feedback Investor contacts SPOTLIGHT ON Press releases SPOTLIGHT ON Our pipelineMedia Back to main Media Media Press releases Media contacts Conferences Media library Our response to the situation in Ukraine Our response to the crisis in Israel and Gaza Our social media RSS feeds FEATURED SECTION Behind the science magazine SPOTLIGHT ON ConferencesCareers Back to main Careers Careers Search jobs Featured careers Careers Featured careers A career in Data Life at GSK Careers Life at GSK What’s your angle? Experienced professionals Careers Experienced professionals Business Operations Engineering at GSK Manufacturing and supply Marketing and sales Research and development Experienced professionals Research and development Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS) Genomic sciences Technology Early talent Careers Early talent Kickstart your career Apprentice programmes Work experience, placements and internships Future leaders graduate programme Early talent Future leaders graduate programme Business operations Engineering Manufacturing Operations, Quality & Supply Chain Marketing and sales Research and development Technology Manufacturing Sciences & Technology Post graduate opportunities Veterans Our global and regional hubs How we hire Careers How we hire Frequently asked questions Fraudulent internet recruitment activities FEATURED SECTION Outstanding people FEATURED SECTION Diversity equity and inclusionHealthcare professionals Healthcare professionals Contact us Contact us Company Ahead Together We unite science, technology and talent to get ahead of disease together. We are GSK 2:48 Close Video Scroll to explore Ahead Together Getting ahead of disease is one of the most inspiring challenges there is on the planet. We aim to positively impact the health of 2.5 billion people by the end of the decade. Our purpose, strategy and culture GSK at a glance Getting ahead of disease in 75 markets worldwide Careers Outstanding people 70,200 GSK people Outstanding people Innovation 4 global R&D centres in US, UK, Belgium and Italy R&D approach Pipeline 71 vaccines and medicines in development Innovation Trust 1st in the Access to Medicine Index for 8th consecutive time Responsibility Performance £30.3bn group turnover in 2023, AER 3% CER 5% Investors Our leadership team Find out more about our board and global leadership team who have overall responsibility for delivering our ambition, strategy and culture. Meet our leaders Board of directors and leadership team Committees Governance Policy positions We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally. Pricing and access Global health and health security Environment Ethical standards Research and development Intellectual property Behind the science Discover how we’re getting ahead ‘Local innovation is vital to our mission to ensure no child is left to suffer from a vaccine preventable disease’ ‘It is both a strategic and a moral imperative’: Why closing the health equity gap is better for everyone ‘Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk’ Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster In the face of climate change, vaccines play a crucial but underestimated role ‘Adult vaccination plays an essential role in healthy ageing, so let’s prioritise prevention and make it a new standard of care’ A preventative patient-centred approach is key to transforming respiratory care and relieving struggling services ‘It can get very serious, very quickly’: the symptoms, risks, and ways to prevent pneumonia everyone should know about ’Prevention is the best medicine to stop disease before it starts’ Millions of people living with chronic hepatitis B are unaware they have the virus. So why aren’t they getting diagnosed? Read our magazine Outstanding people Our people are central to our success. That’s why we’re inspired to help the most diverse and outstanding talent to thrive and be happy at work, in a culture where we’re ambitious for patients, accountable for impact and do the right thing. 1:20 My GSK Story Meet Marc: finding creativity in the art of science View series 14 August 2023 1:43 My GSK story Meet Katie: elevating the voice of the patient View series 04 July 2023 01:16 My GSK story Meet Lorenzo: bringing diverse talent to GSK View series 03 May 2023 03:08 Working together Meet P.J.: how a life-changing diagnosis changed his career View series 09 November 2022 03:19 Innovating Together Meet Melanie: focused on helping more patients with hepatitis B View series 23 September 2022 2:49 Innovating together Meet Mugdha: working together to help more patients View series 11 July 2022 Meet our people You might also like Purpose, strategy and culture At GSK we unite science, technology and talent to get ahead of disease together...
Domain Name: GSK.COM Registry Domain ID: 2466343_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2023-09-21T15:40:09Z Creation Date: 1998-08-07T04:00:00Z Registry Expiry Date: 2024-08-06T04:00:00Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: NS-1070.AWSDNS-05.ORG Name Server: NS-1601.AWSDNS-08.CO.UK Name Server: NS-87.AWSDNS-10.COM Name Server: NS-999.AWSDNS-60.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T14:48:24Z <<<